Full name
WELLNANOPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
WELLNANOPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JERZEGO SAMUELA BANDTKIEGO 19, 30-129 KRAKÓW
TAX ID9442263356
Rate company:
WELLNANOPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9442263356
KRS0000775967
Share capital17,500.00 zł
address
UL. JERZEGO SAMUELA BANDTKIEGO 19, 30-129 KRAKÓW
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9442263356
REGON
382780766
KRS
0000775967
Legal form
limited liability company
Register Address
UL. JERZEGO SAMUELA BANDTKIEGO 19, 30-129 KRAKÓW
Date of registration in KRS
2019-03-08
Date of commencement of economic activity
2019-03-08
Act signature
KR.XI NS-REJ.KRS/14562/24/538
Pkd codes
72.11.Z - Research and experimental development on biotechnology
10.89 - Manufacture of other food products not elsewhere classified
20.20 - Manufacture of pesticides and other agrochemical products
20.42.Z - Manufacture of perfumes and toilet preparations
21.10 - Manufacture of basic pharmaceutical substances
21.20 - Manufacture of medicines and other pharmaceutical products
46.38 - Wholesale of other food, including fish, crustaceans and molluscs
46.45 - Wholesale of perfume and cosmetics
72.11 - Research and experimental development on biotechnology
72.19 - Other research and experimental development on natural sciences and engineering
Payer VAT status
Active
Vat list bank account(s)
PL67 1140 2004 0000 3802 7862 2050 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | -0,5 | -2,3 | -0,7 | 70,8 |
Gross profit (loss) | -0,1 | -0,9 | -0,5 | 41,1 |
EBITDA | -0,9 | -0,5 | 40 | |
Short time liabilities | 1,3 | 2,1 | 56,1 | |
Other operating costs | 0 | 0 | 46 595,4 | |
Equity capital | -0,1 | -1 | -1,3 | -30,8 |
Operating profit (EBIT) | -0,9 | -0,5 | 41,2 | |
Assets | 1,8 | 0,3 | 1,1 | 239 |
Net profit (loss) | -0,1 | -0,9 | -0,5 | 41,1 |
Cash | 0,1 | 0,1 | -40,4 | |
Liabilities and provisions for liabilities | 1,3 | 2,4 | 80,4 | |
Net income from sale | 0 | 0 | 0 | -82 |
Working assets | 1,8 | 0,3 | 1,1 | 239 |
Other income costs | 0,4 | 1,4 | 0,2 | -88,4 |
Depreciation | 0 | 0 | -100 | |
% | % | % | p.p. | |
Profitability of capital | 85,9 | 90,3 | 40,7 | -49,6 |
Equity capital to total assets | -5,6 | -319,5 | -123,2 | 196,3 |
Gross profit margin | -2665,8 | -10 138,6 | -33 119,3 | -22 980,7 |
EBITDA Margin | -9941,8 | -33 065,1 | -23 123,3 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 53 790 | 465 667 | 411 877 | |
Current financial liquidity indicator | 0.23838718235492706 | 0.5175959467887878 | 0,3 |
Financial statements
01-01-2022 - 31-12-2022
Annual financial report
Download xml01-01-2022 - 31-12-2022
Annual financial report
Download pdf01-01-2022 - 31-12-2022
Resolution on profit distribution or loss coverage
Download pdf01-01-2022 - 31-12-2022
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Molecular Biotech Mateusz Gielata
Warszawa
JAROSZ BOŻENA
Lublin
KATARZYNA PAWEŁCZYK SCINT
Wrocław
Bartosz Wasąg
Gdańsk
BIOCELTIX SPÓŁKA AKCYJNA
WROCŁAW